Publications Sep 28, 2017 Eighth Circuit Rules That Policyholder’s Failure To Allocate Settlement Between Covered And Non-Covered Claims Is Fatal To Suit Against Insurers Sep 28, 2017 Florida Appellate Court Rules That Insurer Cannot Assert Defense Based On Insured’s Failure To Comply With Conditions Precedent After Blanket Coverage Denial Sep 28, 2017 Connecticut Supreme Court Rules That Trial Court Improperly Vacated Arbitration Award Sep 28, 2017 Ninth Circuit Rules That “Right To Privacy” Exclusion Relieves Insurer Of Duty To Defend TCPA Suit Sep 28, 2017 Fifth Circuit Rules That Pollution Exclusion Encompasses Asbestos Claims Sep 28, 2017 Pollution Exclusion May Not Bar Coverage For Claims Arising From Oil Leak, Says New Jersey Court Sep 28, 2017 Texas Appellate Court Rules That Automobile Policy Does Not Cover Punitive Damages Sep 28, 2017 Oregon Appellate Court Rules That Contribution Claims Are Barred By State Statute Sep 26, 2017 Form ADV Amendments Effective October 1, 2017 Sep 22, 2017 SEC Issues Updated Guidance on Pay Ratio Disclosure Sep 21, 2017 Key Takeaways from CFIUS’s Annual Report Covering the 2015 Calendar Year Sep 20, 2017 Transferring Patents to Sovereign Entities to Avoid Inter Partes Review Sep 18, 2017 President Trump Blocks Sale of Lattice Semiconductor to Private Equity Fund with Ties to Chinese State-Owned Enterprises, Underscoring Uniquely Difficult Environment for Obtaining CFIUS Approval of Semiconductor Transactions Involving Chinese Investors Sep 18, 2017 First Circuit: Affirms Dismissal of a Securities Fraud Action Challenging Optimistic Statements, “Replete with Caveats,” Concerning FDA Developments Sep 18, 2017 Second Circuit: Supreme Court’s Decision in Salman Abrogated Newman’s “Meaningfully Close Personal Relationship” Test for Tipping Liability Sep 18, 2017 Third Circuit: Describing a Risk as Hypothetical Is Not Misleading Unless That Specific Risk Has Already Materialized Sep 18, 2017 Ninth Circuit: Expressing a Favorable Opinion Concerning FDA Clearance May Be Misleading If the Speaker Does Not Disclose Relevant Adverse FDA Developments Sep 18, 2017 S.D.N.Y.: (1) Courts Must Consider Information in the Public Domain When Assessing the Adequacy of a Company’s Disclosures, and (2) Allegedly Misleading Statements Must Be Viewed in Context Sep 18, 2017 C.D. Cal.: (1) Plaintiffs Must Allege “Concrete” Details to Plead Scienter Under the “Absurd to Suggest” Exception to the Core Operations Theory, and (2) Market Knowledge of the Alleged Fraudulent Practice Is a Prerequisite for Loss Causation Sep 18, 2017 Delaware Chancery Court: (1) MFW’s Framework Governs One-Sided Controller Transactions Involving Disparate Consideration, and (2) MFW’s Procedural Protections Must Be in Place Before the Controller Negotiates for Additional Consideration ...111112113114115116117118119120...